Ascendis Pharma A (ASND) Property, Plant & Equipment (Net) (2012 - 2026)
Ascendis Pharma A (ASND) Property, Plant & Equipment (Net) (2012 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 642,333.36 |
| 2 | Nanobiotix | 1,933.35 Bn | 1,933.29 Bn | - | 5.32 Mn |
| 3 | Akari Therapeutics | 1,063.56 Bn | 1,063.56 Bn | - | - |
| 4 | BeOne Medicines | 468.54 Bn | 463.75 Bn | 1.35 Bn | 1.64 Bn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.20 Bn | 2.59 Bn | 1.61 Bn |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | 5.27 Bn |
| 7 | Belite Bio | 63.57 Bn | 63.57 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Alnylam Pharmaceuticals | 37.75 Bn | 34.74 Bn | 959.66 Mn | 518.26 Mn |
| 10 | Ascendis Pharma A | 15.45 Bn | 14.78 Bn | 268.20 Mn | 159.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 159.13 Mn |
| Mar 31, 2026 | 159.13 Mn |
| Dec 31, 2025 | 170.51 Mn |
| Dec 31, 2025 | 170.51 Mn |
| Sep 30, 2025 | 118.97 Mn |
| Sep 30, 2025 | 118.97 Mn |
| Jun 30, 2025 | 105.89 Mn |
| Jun 30, 2025 | 105.89 Mn |
| Mar 31, 2025 | 97.24 Mn |
| Mar 31, 2025 | 97.24 Mn |
| Dec 31, 2024 | 2.13 Bn |
| Dec 31, 2024 | 2.13 Bn |
| Sep 30, 2024 | 107.10 Mn |
| Sep 30, 2024 | 107.10 Mn |
| Jun 30, 2024 | 112.04 Mn |
| Jun 30, 2024 | 112.04 Mn |
| Mar 31, 2024 | 116.42 Mn |
| Mar 31, 2024 | 116.42 Mn |
| Dec 31, 2023 | -13.75 Mn |
| Dec 31, 2023 | -13.75 Mn |